Our News & Events

News

Phosphorex Welcomes NOF CORPORATION as Shareholder and Strategic Partner

Press Announcing NOF joining Phosphorex as Shareholder and Strategic Partner....

Read more

Phosphorex Appoints John Rigg to Board of Directors

Press Announcing John Rigg as additional Board of Directors...

Read more

Phosphorex and NOF CORPORATION Collaborate to Supply Lipid Nanoparticle Formulations using NOF's Proprietary Ionizable Lipid, COATSOME® SS Series

Press Announcement of Phosphorex's and NOF Corporation Collaboration....

Read more

Phosphorex Expands Leadership Team: Appoints David Tammaro as Chief Financial Officer

Phosphorex, an Ampersand Capital Partners company, and drug delivery-focused contract development and manufacturing organization ("CDMO"), announced today the appointment of David Tammaro as Chief Financial Officer.

Read more

Phosphorex Appoints Jarlath Keating as Chief Executive Officer

Following the recent growth capital investment from Ampersand Capital Partners, Phosphorex announced today the appointment of Jarlath Keating as Chief Executive Officer.

Read more

Phosphorex to Establish cGMP Manufacturing for Lipid Nanoparticles with Growth Capital from Ampersand

Phosphorex, a drug delivery-focused contract development and manufacturing organization providing microspheres and polymer and lipid nanoparticles, today announced a majority recapitalization by Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the health

Read more

Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs)

ONdrugDelivery article to discuss how automation of Lipid Nanoparticles production can benefit the development and manufacture of RNA-based drugs and vaccines.

Read more

Phosphorex and Dolomite Host Collabarative Webinar to Share Their Insights on Making Liposomes and Lipid Nanoparticles (LNPs) with Microfluidics

Phosphorex & Dolomite experts share their insights about the most important considerations when making liposomes and lipid nanoparticles (LNPs) with microfluidics.

Read more

Phosphorex Presents Its Nanosuspension Formulation at CRS Meeting

Phosphorex Presents Its Nanosuspension Formulation at Controlled Release Society Annual Meeting

Read more

Phosphorex and Dolomite Microfluidics Partner to Accelerate Lipid Nanoparticle (LNP) Development

Partnership Creates A Powerful Platform for Pharmaceutical Company Clients.

Read more

Phosphorex Expands Facilities

Phosphorex announced today the acquisition of new laboratory and office space in Hopkinton, MA to meet the increasing demand for its products and services.

Read more

Phosphorex Technologies Showcased at Partnership Opportunities in Drug Delivery (PODD)

AstraZeneca Highlights Collaboration with Phosphorex on use of Zetafinity® Technology to More Effectively Target Immune Cells

Read more

Phosphorex Technologies Highlighted at Nanomedicine and Drug Delivery Symposium (NanoDDS'19)

Matthew Wingate, Director of Process Development, Described how Phosphorex Accelerates Nanomedicine Development from Proof of Concept to Clinical Trials

Read more

Phosphorex CEO Dr. Bin Wu Nominated for 2019 Barry M. Portnoy Immigrant Entrepreneur Awards

The Immigrant Learning Center today announced the nominees for the 2019 Barry M. Portnoy Immigrant Entrepreneur Awards

Read more

Phosphorex at the 44th Controlled Release Society Annual Meeting and Exposition in Boston

Phosphorex, Inc., a leading drug delivery company, today announced its participation in the upcoming Annual Meeting and Exposition of the Controlled Release Society, to be held at the Boston Convention Center, Boston, Massachusetts

Read more